Analyst Ratings for Taysha Gene Therapies (TSHA) [Buys]

TSHA Rating Summary

TSHA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TSHA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $45.41 (+128.2%) * Over Last 12-Mos
Rating Score: 9.1 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/16/2021 Needham & Company Gil Blum New Coverage Buy
(N/A)
45.00
(N/A)
20.50
(19.90)
-2.93% Details
6/24/2021 Truist Securities Joon Lee New Coverage Buy
(N/A)
60.00
(N/A)
25.14
(19.90)
-20.84% Details
Like TSHA Ratings? Also take a look at ORTX, NVTA

TSHA Ratings News